Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:NDZ

(NDZ) (NDZ) Stock Price, News & Analysis

(NDZ) logo

About (NDZ) Stock (NYSE:NDZ)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nordion Inc. (Nordion), is a global health science company. The Company is engaged in products and services used for the prevention, diagnosis and treatment of disease. The Company operates one business unit, Specialty Isotopes. It operates in two segments: Sterilization Technologies and Medical Isotopes. On July 13, 2013, Nordion completed the sale of its Targeted Therapies business to BTG, an international specialist healthcare company based in London, United Kingdom. In August 2014, the Company announced that it has completed the plan of arrangement and all of the outstanding common shares of Nordion Inc have been acquired by an affiliate of Sterigenics International LLC. Effective August 6, 2014, Sterigenics International Inc, a unit of GTCR LLC, acquired the entire share capital of Nordion Inc.

Remove Ads
Receive NDZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (NDZ) and its competitors with MarketBeat's FREE daily newsletter.

NDZ Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

NDZ Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that (NDZ) investors own include Boston Scientific (bsx), Barnes & Noble (BKS), Best Buy (bby), BlackBerry (BB), Arch Biopartners (ARCH), Alpha Natural Resources (ANRZQ) and TD Ameritrade (AMTD).

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NYSE:NDZ
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSE:NDZ) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners